Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118

NCT07033234 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: HS-20118

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.